Connect with us
[adrotate group="2"]


Global Cannabis Leaders – Most Advanced Countries for Medical Research



The United States cannabis market is the largest in the world with sales expected to surpass $92 billion by the end of 2021. Despite this, cannabis is still federally illegal. It is difficult to gauge the full scope of the health and societal problems caused by cannabis prohibition, but we do know that the plant’s illegal status has put millions behind bars, blocked safe access for patients who could benefit from its use, and drastically hindered the ability of researchers to discover more about marijuana’s therapeutic potential.

Although the United States is way behind on the cannabis research front, thankfully a handful of other countries are picking up the slack. A growing number of people are using already using cannabis therapeutically and providing anecdotal data, so the pressure is on for science to catch up by conducting appropriate clinical research and create fair and progressive new laws. Nations like Israel, Canada, and The Czech Republic are changing the global narrative surrounding this plant by offering the world ground-breaking medical studies, quality control laboratory testing, and numerous other types of important research-based services.

Cannabis medicine is the way of the future, and so much more research is needed to understand the full scope of benefits one can experience from using this plant therapeutically. From relieving mental health conditions to curing cancer, it seems there is nothing that marijuana can’t do for our bodies. To learn more, make sure to subscribe to The Medical Cannabis Weekly Newsletter for other articles like this one, as well as exclusive deals on events and products.


No country in the world is better known for cannabis research than Israel. Not only is this the nation where it all began, but they are still paving the path with their modern research efforts today. Back in the early 1960s, Israeli scientist and University Professor, Raphael Mechoulam, first identified and isolated tetrahydrocannabinol (THC) from the cannabis plant. His discovery jumpstarted the medical cannabis revolution and helped change how the entire world looked at this plant.  

Today, Mechoulam is President of The Multidisciplinary Center for Cannabinoid Research at Hebrew University of Jerusalem, where he is leading a team of researchers that continue to uncover the numerous medical benefits associated with the now hundreds of compounds that have been found in cannabis. He has received millions in grants to create cannabis-based treatments for aggressive forms of cancer, and he was recently awarded the Technion Harvey prize for his work in the field.

By 2017, many in the industry had nicknamed Israel “The Holy Land” for medical cannabis; still known as an international hub for some of the most advanced scientists and researchers in the industry and it’s one of the few countries in the world where doctors prescribe cannabis-based medications with some regularity.

A great number of our most important cannabis studies come from Israel, including many about the endocannabinoid system, cannabis and cancer, mental health, addiction, and the list goes on. Israel has seen so much success with cannabis research that more restricted countries (like the U.S.) rely on Israeli data for their own scientific and legal initiatives. Although Israel has been shipping out cannabis products for some time now, many believe the small country’s most valuable export is medical data.


Although Canada tends to get all the glory, Uruguay is actually the first country to legalize the sale and possession of recreational cannabis, which has now been in effect for almost a decade, since 2013. In the industry, Uruguay is known for jumpstarting the federal legalization movement in many different nations, as well as creating the first medical cannabis export program in Latin America that launched in 2019.

Shortly after legalizing adult-use cannabis, Uruguay began to seriously invest in scientific research and was soon recognized as a “hotbed” of medicinal cannabis innovation. Uruguay has many unique advantages that make it a prime location for cannabis research and emerging trends. First is the country’s size and political stability, which make it easy and safe to control cannabis production and distribution.

Also, it is also worth noting is the country’s prime growing location, at a latitude that allows for off-season production to North America and Europe. Their short and mild winter season lasts from around June to August, which means Uruguayans can cultivate cannabis almost year-round. All that, combined with other factors such as transparency, reliability, legal and economic security make Uruguay a perfect region for cannabis industry development.


Malta, officially referred to as The Republic of Malta, is a small Mediterranean country formed by a small group of islands, located south of Italy and east of Tunisia. With a population of just under 500,000 and occupying only 122 square miles, Malta is the smallest country in the European Union, both by land size and population.

However, this small European archipelago is set to become a major global hub for medicinal cannabis research and production. In March of 2018, medical cannabis was officially legalized in Malta, which was followed by the Production of Cannabis for Medicinal and Research Purposes Act a month later. This legislation included all the stipulations for cultivation, processing, consumption, importing and exporting, therein.

Earlier this year, TechforCannEU announced that it had secured funding of up to 2.5 million euros from Malta Enterprise, the nation’s economic development agency, to begin establishing the world’s first medical cannabis industry tech accelerator.

This program offers up-and-coming cannabis entrepreneurs in the areas of healthcare, biotech, agriculture, infrastructure, and digital technology to receive government funding for their work, and thus allows them to reach milestones faster, with less error and expense, ultimately increasing their probability of commercial success. The funds will go directly to the start-up companies selected to participate in the program’s first round.


Canada is the largest to country to legalize recreational cannabis for adults. In 2018, five years after Uruguay, cannabis became the second nation to end prohibition. As one of the most economically secure countries, with a large land mass and decent sized population, Canada has positioned itself as a global leader in numerous different industry sectors including agriculture, investment opportunities, and research.  

Lab testing is a big part of Canada’s cannabis market and the country is home to a very large number of labs across all of its provinces. Well known labs offer the industry a wide variety of testing services including cannabinoid and terpene content, contamination levels, analytical chromatography, and much more. Only lab tested material can be used in the production of cannabis-based medications, and Canada has cornered that sector.

Some of the largest cannabis research centers in the world, including Michael G. DeGroote Centre, McGill, and McMasters, are located in Canada; as well as some of the biggest corporate names in the industry. Companies like Tilray’s, HEXO, and GW Pharmaceuticals – to name a few – are well known to researchers, investors, and consumers alike.

The Netherlands

The Netherlands, Amsterdam specifically, is a region that is well-known for cannabis. Although it is illegal (which is a shock to many), the Netherlands has one of the most lenient marijuana decriminalization policies on earth. Recreational cannabis is used freely by adults and available for purchase and consumption in coffeeshops around the city, some of which have become famous for this exact reason.

In 2003, the Netherlands launched its national medical cannabis program and the country that has long been synonymous with cannabis tourism and redlight districts, suddenly began to make a name for itself as a beacon of marijuana science and testing.

The Netherlands has since received funding for numerous different studies, some of which were very large scale and covered everything from medical applications to treatment of mental disorders, and even limitations on academic performance. Facilities where these trials are conducted can be found all over the country.

Since Amsterdam is stuck in a legislative catch 22 (similar to the US), where cannabis is legal for adults to purchase in the coffee shops, but illegal to produce and sell, the Netherlands are conducting what they refer to as “weed trials”. Starting this year, cafes in 10 different cities will get a legal supply of quality cannabis to sell in their shops as part of a four-year experiment to see if they can deter the nation’s illicit suppliers.

Czech Republic

The Czech Republic legalized medical cannabis in 2013 and is one of many EU countries that have been loosening cannabis restrictions in recent years. What makes the Czech Republic unique, however, is that this Eastern European nation is now home to one of the most advanced and expansive cannabis research facilities in the world: The International Cannabis and Cannabinoids Institute (ICCI).

The ICCI launched in 2015 when a few prominent organizations – Americans for Safe Access (ASA), Prague KOPAC, and Dioscorides Global Holdings (DGH) – joined forces with the Czech Republic’s Minister of Health and created this medical marijuana research hub. The goal is to create a center of excellence that offers the cannabis industry a variety of science-based research services.

According to the website, “The main work of the ICCI is to provide scientific instruments to public and private institutions all over the world. The purpose is to enable scientific examination of the relation between bioactive cannabis compounds and the effect on the human organism in the treatment of specific syndromes and, in the future, systemic health disorders,” said the ICCI CEO Pavel Kubů.

The research conducted at ICCI focuses on three main subjects: Biomedicine, Life Science, and Policy Science. ICCI is an organization that “combines various institutions (universities, high-tech companies, associations) and their capabilities to provide service to the broad array of entities around the world interested in the development of cannabis and cannabinoids as medicine.”


Spain is one of the first European nations to decriminalize personal use of cannabis products for adults, but their medical laws leave much to be desired. It might have something to do with the high rates of tourism in the country. Earlier this year, the committee of the Spanish Congress voted in favor of a that will establish a subcommittee to investigate the effects of regulated medical cannabis programs in other countries.

Regardless of the difficult laws, Spain is the location of numerous largescale cannabis research projects that have helped shed new light on its pharmacological uses. In 1998, researchers at Madrid’s Complutense University found that THC can be used in the treatment of cancer, by activating programmed cell death in certain brain tumor cells without harming surround cells and tissues.

More recently, pharmacologist José-Carlos Bouso, alongside Professor Raphael Mechoulam and Dr. Franjo Grotenhermen from Germany, as well as other leading industry scientists, founded the Spanish Observatory on Medical Cannabis (OECM). The organization is comprised of the top cannabis minds in the industry, and the observatory is said to “promote the works of its members and also highlight the ongoing research done by other Spanish health professionals who are looking into marijuana research.”

What About The United States?

You likely noticed by now that the United States didn’t even make the cut. It may seem surprising that the country with largest global cannabis market is not on the list. So let’s quickly cover the DEA’s Controlled Substances Act, which still, to this day, categorizes “marihuana” as a Schedule 1 narcotic with high likelihood of leading to abuse and addiction, and no known medical applications. According to the scheduling, cannabis is more dangerous than cocaine, but sure, let’s pretend none of that is part of their political smear campaign against a healing plant.

Regardless, US cannabis prohibition has thrown a huge wrench in the wheel of the fast-paced medical research movement. Many of these restrictions can be somewhat avoided during the formation of a recreational market, but when it comes to clinical research, certain criteria needs to be met in order to secure funding and authorization to conduct studies on human subjects. One of the criteria is that the product in question also needs to be legal.

Ultimately, not much has changed here in the last five decades and researchers who do wish to study the plant are limited to acquiring subpar and very limited samples from the only government-approved cannabis production facility in the country – The University of Mississippi School of Pharmacy’s National Center for Natural Products Research, which established the “marijuana project” in 1968.

Weed politics in the US are not pretty, but pressure from the public is mounting to deschedule cannabis and open the gateways for proper research initiatives. Until the laws change, patients will continue fighting for fair access and prominent companies will get their data from elsewhere.

Final Thoughts

As a fun, recreational, adult-use product, all the most popular industry trends will likely come from the US. When considering cannabis as a powerful medicinal product with hundreds of therapeutic compounds to be harnessed and thoroughly studied, look elsewhere in the world. The countries on this list may be lacking the pizazz that our flashy recreational markets possess, but they are leading the way when it comes to research and development, testing, analysis, and data.

Thank you for stopping by CBD TESTERS, your source for all things cannabis-related. Make sure to subscribe to The Medical Cannabis Weekly Newsletter for more informative articles like this one.

Source link

Continue Reading

adult use cannabis

Cannabis Legalization in Canada: Three Years On



Although the world is showing definite progress, full cannabis legalization within a nation is an overall rarity. Georgia, the Netherlands, Mexico, South Africa, Uruguay and 18 states in the US, make up the majority of places that have decided to legalize both medical and recreational cannabis.

Many countries have legalized medical cannabis, but the next step of allowing for recreational use is often a step too far for most nations. Therefore, when Canada took that step in 2018, many people were excited to see how things would change in the country. However, the year is now 2021, and three years have passed. Has the country changed? Has cannabis become easily accessible? Or is Canada in a stagnant position? Let’s find out. 

Since Canada legalized cannabis a few years ago, the entire world has had their eyes on our neighbors up north, and it has been an interesting thus far. To learn more about global cannabis regulation, make sure to subscribe to The Medical Cannabis Weekly Newsletter, your top source for all things cannabis-related including exclusive deals on flowers, vapes, edibles, and other products! Save big on Delta 8Delta 9 THCDelta-10THCOTHCVTHCP & HHC products by checking out our “Best-of” lists!

Cannabis Legalization 

Cannabis legalization is never just as simple as yes or no. The cannabis plant is a complex beast, made up of 100 cannabinoids, and countries have varying laws depending on which cannabinoid is in question. That is where things begin to become complicated. Whilst CBD is legal in the majority of countries around the world, THC is not. This is, most obviously, because CBD is not a psychoactive substance, but THC is. THC is responsible for the well-known ‘high’ that people associate with cannabis. The easiest way to judge a country’s cannabis policy is to look into its views on medical cannabis (used for medicinal purposes) vs its view on recreational cannabis (use for enjoyment).


Medicinal cannabis is cannabis that is used to treat both mental and physical conditions. Both THC and CBD have been found to assist with various health problems. These include: 

  • Chronic pain 
  • Cancer symptoms
  • PTSD
  • Depression
  • Anxiety
  • Tourettes
  • Epilepsy
  • Insomnia 
  • Concentration

Medical cannabis is usually the first one to be legalized in a country, as government’s find it hard to disprove how many people’s conditions have been improved by the wonders of cannabis. The evidence is often a slap in the face to any anti-drug governments; it’s impossible to ignore. 


On the other hand, recreational cannabis is a tougher subject. Legalizing any drug for the sole purpose of allowing people to use it for fun is always something that governments find hard to do. It requires an overall trust in the population and solid knowledge of drugs. However, some would argue that any use of cannabis is, in a way, medication. Halcyon Organics states:

“I encourage all “recreational” cannabis users to reevaluate their use.  If there is a prescription or over-the-counter drug designed to treat something that cannabis helps you with, that’s medical use.  If they sell something at GNC or Vitamin World that cannabis helps you with, that’s medical use.  You may not use these other medications because you already know that cannabis is a superior treatment, you just didn’t realize it.

However, most countries do not have this view. That is why the legalization of recreational cannabis is a lot rarer than medicinal. But for those countries that have legalized both uses of cannabis, does it always lead to better conditions? Are the people who need cannabis any closer to getting it after their country has fully legalized cannabis? Let’s take a look at some of the problems that can arise in nations that say yes to marijuana.

Problems That Arise


When cannabis is legalized, the price is always majorly important. Usually those in need of cannabis will have had to get their medication from street dealers and the dark web before legalization has taken place. Therefore, it’s important that when cannabis is legalized, the companies are able to match or even beat the prices of those other sources. If not, it will be extremely difficult for those who are unable to afford the cost of prescriptions. They may be forced to return to their previous sources and risk being prosecuted and fined. In Amsterdam, the prices stay low due to the heavy competition between coffee shops. There are over 160 establishments that sell cannabis in the capital of the Netherlands, which means a lot of healthy competition and, in result, cheap weed. 


Accessibility is another issue that rises once cannabis has been legalized. How easy is it to get a hold of? Some countries require a huge amount of evidence from a doctor before being able to retrieve medical cannabis. This is difficult if health providers have not done proper research into cannabis as a medicine, and which illnesses require it. In addition, if there aren’t many cannabis shops or dispensaries within a city, it can be difficult for someone to purchase cannabis. Especially if they are unable to travel. This is, again, when street dealers and the dark web become an easier option. 

Cannabis In Canada

On the 17th October 2018, Canada legalized cannabis in all areas for adults 18 and over. This made Canada only the second country in the world to legalize recreational cannabis. The first was Uruguay in 2013. Under the Cannabis Act of 2018, the sale and production of cannabis products became legal by territorial retailers and federally licensed sellers of cannabis for medical purposes. 

What’s Legal?

In Canada it’s legal to purchase cannabis from specific establishments, it’s legal to consume cannabis and it’s legal to grow up to 4 cannabis plants at home. You’re able to sell cannabis only if you’re licensed by Health Canada. Medical cannabis is also legal and prescribed if authorized by a healthcare provider. 

What’s Illegal?

Selling cannabis without a license is illegal and dealt with strictly. In addition, driving high is of course illegal. The police force in Canada are especially trained in identifying high drivers. 

Why did Canada Legalize Cannabis?

Canada decided to legalize cannabis as a national experiemnet. They wanted to see if by legalizing cannabis, they would be able to regulate and own the problems that surround the drug. So why did they want to fully legalize cannabis?


One reason was to conquer inequality.

“Legalization, the government vowed, would address the inequalities in a criminal justice system where marijuana and hashish penalties and prosecutions — and the lifelong burdens they impose — had fallen disproportionately on marginalized communities, particularly Black Canadians and Indigenous people.”

They hoped that by legalizing cannabis, strict penalties on minority groups would diminish and as such not have long-term effects on their lives. 


The Canadian government also hoped that by legalizing cannabis, it would become more accessible to those who desperately need it. They hoped this would also then avoid people being prosecuted or fined when using cannabis as medication.

Youth Cannabis Consumption

Another issue that Canada was facing was the amount of young people consuming cannabis. They wanted to regulate cannabis and the legal age of consumption in order to stop youngsters from purchasing it. 


Finally, Canada wanted to benefit from the taxation on cannabis sales. The Netherlands are widely known to make around 400 million euros from cannabis sales in coffeeshops. This money can be used to put back into the economy.

How’s It Going Three Years Later?

So, the question is, after three years how is Canada’s cannabis experiment going? Have their aims been achieved or is it still too early to tell? 

Well, in regards to inequality, cannabis legalization has slightly dealt with this. National prosecutions were at 26,000 in 2018, and have now dropped significantly to 46 only. It’s still illegal to possess over 30 grams of cannabis in Canada. This has, evidently, also benefited those who were most likely to be prosecuted: minority groups. However, an important statistic to remember is that within the new cannabis industry, 84% of directors and executives are white males. So the cannabis industry in Canada is hardly diverse itself. 

Has cannabis become more accessible? Well, there are over 2000 cannabis stores in Canada, and this number is definitely rising. In addition:

“According to the government’s most recent survey, 27 per cent of participants reported having used marijuana in the past year — an increase from 22 per cent in the first cannabis survey conducted in 2017” 

Plus, the prices of legal cannabis is definitely going down. In 2020, the average price of a gram in Canada was around $11 a gram, whereas in 2021 it’s now around $9 a gram. This shows an obvious decrease and that the industry is benefitting from healthy competition between retailers.

Are Canada’s youth being deterred from cannabis consumption? Well, the truth is that it’s hard to fully find this out at this point in time. But, there’s no doubt that cannabis shops are far more strict on age checks than street dealers are. Shop owners could risk losing their licenses if they aren’t. Therefore, it’s unlikely that cannabis is being sold to underage children legally. However, it’s hard to tell if this is still happening illegally. 

And finally, what about taxation? Well, in 2020, Canada made $2.6 billion from cannabis sales. This is a 120% increase from 2019. This statistic alone proves that cannabis taxation is working within the reasonably new Canadian cannabis industry. 

What do you think? 

So, there you have it, Canada three years after they legalized cannabis. Do you think their country has improved, or could they be doing more to truly benefit from legal cannabis? The truth is, Canada set the standards for cannabis legalization round the world in 2018, let’s hope they can continue that. 

Hello all! Welcome to, your ultimate online destination for the most relevant and thought-provoking cannabis and psychedelics-related news globally. Read-thru the site regularly to stay on top of the constantly-moving world of legal drugs and industrial hemp, and sign up for The Medical Cannabis Weekly Newsletterso you never miss a thing.

Source link

Continue Reading


Canada to Reopen Border, Travelers Reminded Cannabis is Prohibited



On both sides of some areas of the U.S.-Canada border, cannabis is legal for adult use, but that doesn’t mean you can take cannabis through customs of an international border. Don’t even think about it—because officials from both sides say they won’t tolerate it and it can still get you into serious trouble.

Canada is opening their border to vaccinated American travelers beginning on August 9, but despite cannabis being legal for adult use in New York state and Canada, it’s still illegal to take it between the two countries. It’s the same story in ports of entry in Washington state, Michigan, Maine and other areas.

Travelers must have received their vaccine at least 14 days before arriving at the border. Next, they must provide all COVID-19 related information electronically through the ArriveCAN app or web portal. Finally, travelers must have physical proof of vaccination (i.e. a paper card) to present at the border.

Canada has a Border Problem

It’s easy to forget a passport, or even worse, forget that you have weed in the car when there isn’t much time to turn the car around. But if you get caught with weed, you will almost certainly be denied entry to the U.S., regardless of state-legal medical cards, and could be given a ticket or arrested at their discretion.

Mike Niezgoda is a public affairs officer with the U.S. Customs and Border Protection, and said there have been a number of smuggling cases even though cannabis is legal on both sides.

“We had an incursion that came via helicopter that landed in Grand Island, just north of Buffalo,” Niezgoda told WXXI News. In 2019. Border Patrol agents recovered four duffel bags carrying a total of more than 100 pounds of cannabis with an estimated street value of more than $100,000.

But Niezgoda sees smaller infractions happen more often—unintended smuggling because people have cannabis in their cars and forget about it. “Say they went to Toronto to go up to see the Maple Leafs play the Sabres, they bought some marijuana, and then they forgot about it and then came back and they realized it right when they saw the booth,” he said.

That could result in potentially serious charges, because U.S. Customs and Border Protection agents default to federal law.

What to Do if You Have Cannabis at a Canada Port of Entry

When Canada first legalized cannabis, the parliamentary secretary to Canada’s minister of public safety told Canadians that they should “be honest and tell the truth” when asked if they’ve smoked weed at the U.S.-Canada border.

But U.S. Customs and Border Protection agents can ban you from entering the United States even for admitting that you’re there to smoke cannabis and party. For this reason, an immigration lawyer told Vice that he recommends being silent about plans to smoke weed when crossing the border.

Having cannabis in the car could be worse. The best thing to do is to just pay attention to what’s in your car and prevent accidental smuggling charges. In some ports of entry, there are places where you can do a U-turn and find a place to dispose of cannabis. “It depends on the port of entry,” Niezgoda said. “Some ports of entry have areas where they could U-turn and some do not.”

If travelers are caught throwing a bag of weed out the window, officials say that they face littering charges on top of cannabis possession. Officials claim that it’s better to declare cannabis in the vehicle, but it could result in a fine or arrest. 

To avoid all of that, he said travelers would be wise to leave the cannabis at home or dispose of it before reaching the border in the first place.

Source link

Continue Reading

aurora cannabis

Aurora Cannabis Company Delivers Record-Breaking $8 Million in Cannabis Product to Israel



Canadian cannabis producer Aurora Cannabis Inc. announced on July 15 that it officially delivered one of the largest shipments of cannabis to Israel to date.

The company completed a record-breaking delivery defined as “nearly C$8 million”—one of the company’s largest shipments. “We are excited about the evolution of the cannabis industry in Israel and commend the Ministry of Health and the Israeli Medical Cannabis Agency for ensuring thoughtful regulation of cannabis, in the best interest of Israeli cannabis patients,” said Chief Executive Officer of Aurora Cannabis Inc. Miguel Martin.

He continued, “We look forward to continuing to provide high-quality cannabis to Israel, as part of our strategy to expand our medical cannabis portfolio in key international markets.”

Aurora Cannabis Inc. has been supplying Israel-based Cantek Global Ltd., a leading medical cannabis enterprise, with dried cannabis flower for a few months now, through a strategic supply agreement that the two company’s established with one another. The agreement, which was officially announced in November 2020, requires a minimum of 4,000kg of bulk dried flower to be shipped annually to Israel for a total of two years with the option to extend later.

In a press statement, Martin praised the two companies’ opportunity to expand their international cannabis brands and make history. “It’s about the strength and quality of the Aurora medical brand being validated once again by the world’s medical cannabis markets, including countries like Israel in which we had no distribution prior to today. We consider this Agreement to be a significant step for Aurora, and we look forward to bringing our high-quality medical cannabis products to patients in Israel.” Cantek Global Ltd. has partnerships with “local drugstores chains, distribution companies, clinics.”

Aurora Cannabis is an International Cannabis Brand

Aurora Cannabis Inc., a big player in the Canadian cannabis industry, as well as throughout the world, has also become a large producer of flower for the German cannabis market as well, despite need to cull part of its European workforce back in July 2020. On May 25, the company officially began trading on The Nasdaq Global Select Market under the ticker symbol “ACB” (which is separate from its listing on the Toronto Stock Exchange as “TSX: ACB”).

In June, the company was interviewed by BNN Bloomberg regarding its push for unique genetics in order to stand out from other Canadian competition. “We have a lot of great genetics that we can work on but we’re already moving beyond what we had,” said Aurora’s Senior Vice President of Science and Innovation Charles Pick. “We’re taking plants that are already super interesting and we’re crossing them and being able to produce hundreds, if not thousands of seeds.”

Like many cannabis companies, Aurora released a statement in support of the United States’ recently proposed federal cannabis bill. “The introduction of the Cannabis Administration and Opportunity Act is a watershed moment for cannabis-related public policy in the United States. Aurora welcomes this proposed legislation and what its passage would mean for the health, wellbeing, and livelihoods of millions of Americans—especially communities of colour and all those disproportionately affected by cannabis prohibition, punitive penalties, and linger stigma,” the company wrote on Twitter.

“As one of Canada’s—and the world’s—largest licensed cannabis producers, Aurora is no stranger to a regulatory undertaking that’s national in scope. We’re ready and willing to work with legislators in the United States on making continued progress towards cannabis policies that prioritize safety, wellbeing, justice, and common sense. With the introduction of this legislation, we are hopeful that cannabis policy will continue to evolve in the United States, and will soon reflect the American public’s overwhelming support for legalization.”

Source link

Continue Reading